Restart Life Sciences Company Description

Restart Life Sciences Corp., through its subsidiaries, operates as a biotechnology company worldwide.

It engages in developing diagnostics and psilocybin-based therapeutics for the treatment of neuroinflammatory disorders, including autism spectrum disorder and fragile X syndrome.

The company was formerly known as Nova Mentis Life Science Corp. and changed its name to Restart Life Sciences Corp. in November 2024.

Restart Life Sciences Corp. was incorporated in 2004 and is based in Vancouver, Canada.

Restart Life Sciences Corp.

Country	Canada
Founded	2004
Industry	Biological Products, Except Diagnostic Substances
CEO	Steve Loutskou

Contact Details

Address: 700-838 West Hasting Street Vancouver, British Columbia V6C 0A6 Canada
Phone	778 819 0244
Website	restartlife.co

Stock Details

Ticker Symbol	HEAL
Exchange	Canadian Securities Exchange
Fiscal Year	January - December
Reporting Currency	CAD
SIC Code	2836

Key Executives

Name	Position
Steve Loutskou	Chief Executive Officer
Rebecca Hudson	Chief Financial Officer